Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 27.96
+0.81 (2.98%)
At close: Apr 8, 2026
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 11.84 billion as of April 8, 2026. Its market cap has increased by 28.43% in one year.
Market Cap
11.84B
Enterprise Value
11.68B
Revenue
674.49M
Ranking
n/a
PE Ratio
508.44
Stock Price
27.96
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 11.84B, an increase of 43.37%. That is a compound annual growth rate of 9.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 11.50B | -6.35% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Henan Lingrui Pharmaceutical | 12.38B |
| Zhejiang Hisun Pharmaceutical | 12.25B |
| Shanghai Yizhong Pharmaceutical | 12.04B |
| Yantai Dongcheng Pharmaceutical Group | 12.02B |
| Porton Pharma Solutions | 11.64B |
| Zhejiang CONBA Pharmaceutical | 11.16B |
| Beijing Foyou Pharma CO.,LTD | 11.07B |
| Mayinglong Pharmaceutical Group | 10.90B |